Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: Inhibition by protein phosphatase-2A

Diabetologia

Volumn 51, Issue 6, 2008, Pages 1068-1080

  Campbell, M ^a,b   Anderson, P ^a   Trimble, E R ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Diabetes; ERK; Extracellular regulated protein kinase; PDGF BB; PKC; Platelet derived growth factor BB

Indexed keywords

ALDEHYDE REDUCTASE; CHEMOATTRACTANT; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C BETA INHIBITOR;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

AORTA; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CHEMOTAXIS; GLUCOSE; HUMANS; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTEIN PHOSPHATASE 2; RNA, SMALL INTERFERING;

EID: 43049098151     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0962-7     Document Type: Article

References (39)

1. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581
2. Higuchi ML, Gois JM, Reis MM et al (2006) Co-infection ratios versus inflammation, growth factors and progression of early atheromas. APMIS 114:338-344
3. Waltenberger J (1997) Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation 96:4083-4094
4. Kawano M, Koshikawa T, Kanzaki T, Morisaki N, Saito Y, Yoshida S (1993) Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF beta-receptors. Eur J Clin Invest 23:84-90
5. Lev-Ran A, Hwang DL (1990) Epidermal growth factor and platelet-derived growth factor in blood in diabetes mellitus. Acta Endocrinol (Copenh) 123:326-330
6. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
7. Campbell M, Allen WE, Sawyer C, Vanhaesebroeck B, Trimble ER (2004) Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res 95:380-388
8. Campbell M, Trimble ER (2005) Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbII. Circ Res 96:197-206
9. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK (2005) Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 54:818-829
10. Ballagi AE, Ishizaki A, Nehlin JO, Funa K (1995) Isolation and characterization of the mouse PDGF beta-receptor promoter. Biochem Biophys Res Commun 210:165-173
11. Campbell M, Allen WE, Silversides JA, Trimble ER (2003) Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-beta receptor potentiates vascular smooth muscle cell chemotaxis. Diabetes 52:519-526
12. Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316
13. Barrett TB, Benditt EP (1987) sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci U S A 84:1099-1103
14. Clunn GF, Refson JS, Lymn JS, Hughes AD (1997) Platelet-derived growth factor beta-receptors can both promote and inhibit chemotaxis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2622-2629
15. Knapp J, Aleth S, Balzer F, Schmitz W, Neumann J (2002) Calcium-independent activation of the contractile apparatus in smooth muscle of mouse aorta by protein phosphatase inhibition. Naunyn Schmiedebergs Arch Pharmacol 366:562-569
16. Millward TA, Zolnierowicz S, Hemmings BA (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24:186-191
17. Sharpe PC, Yue KK, Catherwood MA, McMaster D, Trimble ER (1998) The effects of glucose-induced oxidative stress on growth and extracellular matrix gene expression of vascular smooth muscle cells. Diabetologia 41:1210-1219
18. Tanimoto T, Lungu AO, Berk BC (2004) Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 94:1050-1058
19. Natarajan V, Scribner WM, Hart CM, Parthasarathy S (1995) Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res 36:2005-2016
20. Cho HM, Choi SH, Hwang KC et al (2005) The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. Mol Cells 19:60-66
21. Richter A, Davies DE, Alexander P (1995) Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. Biochem Pharmacol 49:367-373
22. Mahadevan VS, Campbell M, McKeown PP, Bayraktutan U (2006) Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity. Cardiovasc Res 72:60-68
23. Hughes AD, Clunn GF, Refson J, Demoliou-Mason C (1996) Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen Pharmacol 27:1079-1089
24. Sjolund M, Rahm M, Claesson Welsh L, Sejersen T, Heldin CH, Thyberg J (1990) Expression of PDGF alpha- and beta-receptors in rat arterial smooth muscle cells is phenotype and growth state dependent. Growth Factors 3:191-203
25. Webb SE, Pollard JW, Jones GE (1996) Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1. J Cell Sci 109:793-803
26. Funa K, Uramoto H (2003) Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor. Acta Biochim Pol 50:647-658
27. Dardik A, Yamashita A, Aziz F, Asada H, Sumpio BE (2005) Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. J Vasc Surg 41:321-331
28. Haj FG, Markova B, Klaman LD, Bohmer FD, Neel BG (2003) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278:739-744
29. Takehara N, Kawabe J, Aizawa Y, Hasebe N, Kikuchi K (2000) High glucose attenuates insulin-induced mitogen-activated protein kinase phosphatase-1 (MKP-1) expression in vascular smooth muscle cells. Biochim Biophys Acta 1497:244-252
30. Chen J, Parsons S, Brautigan DL (1994) Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J Biol Chem 269:7957-7962
31. Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol 286:E686-E696
32. Zhang J, Fu M, Myles D et al (2002) PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. FEBS Lett 521:180-184
33. Dhore CR, Cleutjens JP, Lutgens E et al (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998-2003
34. Zhou B, Wang ZX, Zhao Y, Brautigan DL, Zhang ZY (2002) The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J Biol Chem 277:31818-31825
35. Huang W, Batra S, Atkins BA, Mishra V, Mehta KD (2005) Increases in intracellular calcium dephosphorylate histone H3 at serine 10 in human hepatoma cells: potential role of protein phosphatase 2A-protein kinase CbetaII complex. J Cell Physiol 205:37-46
36. Michell BJ, Chen Z, Tiganis T et al (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625-17628
37. Chung SS, Chung SK (2003) Genetic analysis of aldose reductase in diabetic complications. Curr Med Chem 10:1375-1387
38. Haller H, Drab M, Luft FC (1996) The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy. Clin Nephrol 46:246-255
39. Colhoun HM, Betteridge DJ, Durrington PN et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696